All Entries in the "Dangerous Drugs" Category
Lo/Ovral-28 (Norgestrel/EthinylEstradiol) Tablets: Recall – Possibility of Inexact Tablet Counts or Out of Sequence Tablets
Oral contraceptive daily regimen may be incorrect and could leave women without adequate contraception, and at risk for unintended pregnancy.
Xigris [drotrecogin alfa (activated)]: Market Withdrawal – Failure to Show Survival Benefit
In a recent study, Xigris failed to show a survival benefit for patients with severe sepsis and septic shock.
Sprycel (dasatinib): Drug Safety Communication – Risk of Pulmonary Arterial Hypertension
Patients should be evaluated for signs and symptoms of underlying cardiopulmonary disease prior to starting Sprycel, as well as during treatment.
Virility Max: Recall – Undeclared Drug Ingredient
Product marketed as dietary supplement contains sulfoaildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.
Chantix (varenicline)
UPDATED 10/24/2011. Updated study data. Healthcare professionals should continue to monitor patients for neuropsychiatric symptoms.
Trilipix (fenofibric acid): Drug Safety Communication – Label Change
The ACCORD Lipid trial found no significant difference in the risk of a major adverse cardiac event between group treated with fenofibrate plus simvastatin compared with simvastatin alone.
Mizuho OSI Modular Table Systems: Class I Recall – Reports of Patient Injury
Potential for patient falls or unanticipated patient movement, which may result in serious injury or death.
Benicar (olmesartan): Ongoing Safety Review
FDA evaluating data in which type 2 diabetes patients taking Benicar had a higher rate of death from cardiovascular cause compared to placebo. FDA has not concluded that Benicar increases the risk of death.
Vitamin D Supplement Products: Medication Use Error
Some liquid Vitamin D supplement products are sold with droppers that could allow parents to accidentally give harmful amounts of Vitamin D to their infant.
McNeil Consumer Healthcare Over-The-Counter Products: Recall
UPDATED 06/17/2010. Recall expanded to include product lots of Benadryl Allergy Ultratab Tablets and Extra Strength Tylenol Rapid Release Gels.
Magic Power Coffee: Undeclared Drug Ingredient
Product marketed as a dietary supplement for sexual enhancement contains the drug ingredient hydroxythiohomosildenafil, a chemical that may interact with prescription nitrates, and cause dangerously low blood pressure.
